<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:CDNA (USA) Also Trade In: Germany

CareDx Inc $ 26.17 -0.15 (-0.57%)

Volume:
753,331
Avg Vol (1m):
869,371
Market Cap $:
1.11 Bil
Enterprise Value $:
1.07 Bil
P/E (TTM):
0.00
P/B:
11.82
Warning! GuruFocus has detected 3 Severe warning signs with CDNA. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for CDNA (CareDx) from 2014 to Oct 19 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. CareDx stock (CDNA) PE ratio as of Oct 19 2019 is 0. More Details

CareDx PE Ratio (TTM) Chart

EMBED

CareDx PE Ratio (TTM) Historical Data

Total 1251
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
CareDx PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2019-10-190.0 2019-08-190.0
2019-10-180.0 2019-08-160.0
2019-10-170.0 2019-08-150.0
2019-10-160.0 2019-08-140.0
2019-10-150.0 2019-08-130.0
2019-10-140.0 2019-08-120.0
2019-10-110.0 2019-08-090.0
2019-10-100.0 2019-08-080.0
2019-10-090.0 2019-08-070.0
2019-10-080.0 2019-08-060.0
2019-10-070.0 2019-08-050.0
2019-10-040.0 2019-08-020.0
2019-10-030.0 2019-08-010.0
2019-10-020.0 2019-07-310.0
2019-10-010.0 2019-07-300.0
2019-09-300.0 2019-07-290.0
2019-09-270.0 2019-07-260.0
2019-09-260.0 2019-07-250.0
2019-09-250.0 2019-07-240.0
2019-09-240.0 2019-07-230.0
2019-09-230.0 2019-07-220.0
2019-09-200.0 2019-07-190.0
2019-09-190.0 2019-07-180.0
2019-09-180.0 2019-07-170.0
2019-09-170.0 2019-07-160.0
2019-09-160.0 2019-07-150.0
2019-09-130.0 2019-07-120.0
2019-09-120.0 2019-07-110.0
2019-09-110.0 2019-07-100.0
2019-09-100.0 2019-07-090.0
2019-09-090.0 2019-07-080.0
2019-09-060.0 2019-07-050.0
2019-09-050.0 2019-07-040.0
2019-09-040.0 2019-07-030.0
2019-09-030.0 2019-07-020.0
2019-09-020.0 2019-07-010.0
2019-08-300.0 2019-06-280.0
2019-08-290.0 2019-06-270.0
2019-08-280.0 2019-06-260.0
2019-08-270.0 2019-06-250.0
2019-08-260.0 2019-06-240.0
2019-08-230.0 2019-06-210.0
2019-08-220.0 2019-06-200.0
2019-08-210.0 2019-06-190.0
2019-08-200.0 2019-06-180.0

CareDx PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Medical Diagnostics & Research » Medical Diagnostics & Research NAICS : 325413 NAICS : 8071
Traded in other countries 1K9.Germany CDNA.USA
Address 3260 Bayshore Boulevard, Brisbane, CA, USA, 94005
CareDx Inc is a commercial-stage company. It develops, markets and delivers diagnostic surveillance solutions for organ transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. The portfolio of the group includes product such as Allomap, Allosure, and Olerup. The Allomap is a gene expression test that helps clinicians monitor and identifies heart transplant recipients; AlloSure, is a next-generation sequencing-based test to detect donor-derived cell-free DNA after transplantation; and Olerup is a set of human leukocyte antigen typing used prior to hematopoietic stem cell/bone marrow transplantation and organ transplantation. Geographically the business activity is functioned through the US.